What is the current Adult and Pediatric Vaccines market size?

The current market size is approximately USD 43.8 billion as of 2022.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 10.5% from 2023 to 2028.

What are the key drivers of the Adult and Pediatric Vaccines market?

Increasing disease prevalence and advancements in vaccine technology drive market growth.

What are the major challenges facing the Adult and Pediatric Vaccines market?

Vaccine hesitancy and supply chain disruptions pose significant challenges.

Which regions are leading the Adult and Pediatric Vaccines market?

North America and Europe are the leading regions due to high vaccine adoption.

Who are the top companies in the Adult and Pediatric Vaccines market?

Pfizer, Merck, and GSK are among the top companies in the market.

What future opportunities exist in the Adult and Pediatric Vaccines market?

Emerging markets and innovative vaccine technologies present future growth opportunities.

How is technology impacting the Adult and Pediatric Vaccines market?

Advances in vaccine technology and digital health platforms enhance market growth.

What is the current regulatory landscape for the Adult and Pediatric Vaccines market?

Stringent regulations and safety standards govern the market, ensuring vaccine efficacy.

What is the future outlook for the Adult and Pediatric Vaccines market size?

The market is expected to reach USD 64.2 billion by 2028, driven by increasing demand.

Adult and Pediatric Vaccines - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Adult and Pediatric Vaccines by Application (Hospitals, Medical Care Centers, Others), by Types (Adult Vaccines, Pediatric Vaccines), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 23, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Adult and Pediatric Vaccines Market Size | CAGR 15.2 Forecast 2033

Adult and Pediatric Vaccines - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 23, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $4500 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Adult and Pediatric Vaccines Market Overview

The Adult and Pediatric Vaccines market refers to the global industry involved in the development, production, and distribution of vaccines for adults and children. As a crucial sector in the healthcare industry, the Adult and Pediatric Vaccines market size is estimated to be around $43.8 billion in 2025. The growth outlook for this market is promising, with a projected market forecast of $64.5 billion by 2033, driven by increasing demand for immunization and advancements in vaccine technology. The market forecast indicates a compound annual growth rate (CAGR) of 5.5% during the forecast period, 2026-2033, signaling a steady industry expansion. The scope of this market encompasses various vaccine types, including inactivated, live attenuated, and conjugate vaccines, as well as different applications, such as preventive and therapeutic uses.

Loading chart…

Several key forces are shaping the Adult and Pediatric Vaccines industry, including technology shifts towards more effective and safer vaccines, regulations governing vaccine development and approval, and consumer behavior driven by increasing awareness of vaccine importance. The largest region in the Adult and Pediatric Vaccines market is currently North America, while the fastest-growing region is Asia-Pacific, driven by expanding healthcare infrastructure and growing demand for vaccines. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and developments to capitalize on emerging opportunities and navigate challenges effectively.

Report Overview

Report Attribute	Details
Market size value in 2025	4.50 billion
Revenue forecast in 2033	13.96 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GlaxoSmithKline; Sanofi; Merck; Novartis; Pfizer; AstraZeneca; Johnson & Johnson; Takeda Pharmaceutical; Bavarian Nordic; LG Life Sciences; Sinovac Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Adult and Pediatric Vaccines market is poised for significant growth, driven by various factors that are shaping its dynamics. Understanding these market dynamics is crucial for stakeholders to navigate the complex landscape and capitalize on emerging opportunities.

Growth Drivers2 items

Increasing demand for vaccines due to rising awareness about preventive care and the importance of vaccinations in preventing infectious diseases, which is expected to drive the Adult and Pediatric Vaccines market size and growth forecast.

Advancements in technology and vaccine development, enabling the creation of more effective and safer vaccines, thus contributing to the growth of the Adult and Pediatric Vaccines market.

Restraints2 items

Stringent regulatory requirements and complex approval processes for new vaccines, which can hinder the pace of innovation and limit the Adult and Pediatric Vaccines market growth.

High development costs and significant investment required for vaccine research and development, posing a challenge for manufacturers and impacting the overall Adult and Pediatric Vaccines market size.

Opportunities2 items

Emerging markets and expanding healthcare infrastructure in developing countries, presenting opportunities for vaccine manufacturers to increase their market share and contribute to the growth forecast of the Adult and Pediatric Vaccines market.

Growing focus on personalized medicine and targeted therapies, which could lead to the development of novel vaccines and boost the Adult and Pediatric Vaccines market.

Challenges2 items

Addressing vaccine hesitancy and misinformation, which can affect vaccination rates and pose a significant challenge to the growth of the Adult and Pediatric Vaccines market.

Managing supply chain complexities and ensuring a stable vaccine supply, especially during pandemic situations, to meet the demand and maintain the integrity of the Adult and Pediatric Vaccines market.

Market Segmentation

Loading chart…

The Adult Vaccines market can be segmented based on Application and Types. In terms of application, adult vaccines are used to prevent various diseases such as influenza, pneumonia, and hepatitis. The types of adult vaccines include inactivated vaccines, live attenuated vaccines, and conjugate vaccines. Understanding the Adult and Pediatric Vaccines segmentation is crucial for market players to develop targeted strategies and products. The application segment contributes significantly to the overall market size, with a growing demand for vaccines against emerging diseases.

The Pediatric Vaccines market is also segmented based on Application and Types. Pediatric vaccines are used to prevent diseases such as measles, mumps, and rubella. The types of pediatric vaccines include combination vaccines, monovalent vaccines, and toxoid vaccines. The market taxonomy of pediatric vaccines reveals a significant contribution from the application segment, driven by government initiatives and recommendations for routine vaccinations. The types of vaccines also play a crucial role in determining the market size, with a growing trend towards combination vaccines for better protection against multiple diseases.

Adult and Pediatric Vaccines Segmentation Breakdown7 items

Application

Hospitals

Medical Care Centers

Others

Types

Adult Vaccines

Pediatric Vaccines

Regional Insights

Loading chart…

The Adult and Pediatric Vaccines market growth is expected to vary across regions, with the Asia Pacific region being the largest, accounting for approximately 35% of the global market, and the Latin America region being the fastest-growing, driven by increasing adoption of vaccines and government policies supporting immunization programs.

Key drivers for each region include: for North America, investments in research and development, demographics with an aging population, and a mature ecosystem; for Europe, policies supporting vaccine development, infrastructure for distribution and storage, and a strong ecosystem; for Asia Pacific, large demographics, increasing adoption of vaccines, and growing investments in healthcare; for Latin America, government policies supporting immunization programs, increasing adoption of vaccines, and growing investments in healthcare infrastructure; and for Middle East & Africa, growing demographics, increasing adoption of vaccines, and investments in healthcare infrastructure.

The regional forecast indicates that the Asia Pacific region will continue to dominate the market, driven by large demographics and increasing adoption of vaccines, while the Latin America region will experience the fastest Adult and Pediatric Vaccines market growth, driven by government policies and growing investments in healthcare.

Competitive Landscape

The Adult and Pediatric Vaccines market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. Key competitive levers in this market include pricing, distribution, product innovation, certifications, and regulatory approvals. The Adult and Pediatric Vaccines competitive landscape is characterized by high competition, with companies employing various strategies to differentiate themselves and maintain market share.

Companies in this market employ common strategies such as M&A, partnerships, product launches, expansion, R&D, and localization to stay competitive. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. The following companies have adopted distinct strategic focuses:

GlaxoSmithKline: regional expansion

Sanofi: innovation pipeline

Merck: premium pricing

Novartis: local manufacturing

Pfizer: vertical integration

AstraZeneca: OEM tie-ups

Key Adult and Pediatric Vaccines Companies11 items

GlaxoSmithKline

Sanofi

Merck

Novartis

Pfizer

AstraZeneca

Johnson & Johnson

Takeda Pharmaceutical

Bavarian Nordic

LG Life Sciences

Sinovac Biotech

Market Ecosystem

The Adult and Pediatric Vaccines ecosystem spans the entire value chain, from upstream technology providers and suppliers to midstream integrators and downstream channels, ultimately reaching end-users. This complex network creates and captures value through the development, manufacturing, and distribution of vaccines. Understanding the interplay between these stakeholders is crucial for conducting a comprehensive value chain analysis.

Raw material/component suppliers — providing essential components

OEMs / manufacturers — producing vaccines

Distributors / channel partners — delivering vaccines to healthcare providers

Service providers / after-sales — offering support and maintenance services

End users / buyers — healthcare providers and patients

Regulators/standards bodies — overseeing safety and efficacy standards

Data/analytics providers — providing insights for vaccine development and distribution

In the Adult and Pediatric Vaccines ecosystem, control points are predominantly held by regulators and standards bodies, influencing adoption through strict safety and efficacy standards. Dependency risks arise from input constraints, such as limited supply of raw materials, and approvals from regulatory bodies. Switching costs are high due to the specialized nature of vaccine development and manufacturing, leading to long-term partnerships between stakeholders. The ecosystem's structure and dynamics can differ by region, with varying regulatory requirements and healthcare infrastructure influencing the flow of value.

Recent Industry Insights

The Adult and Pediatric Vaccines industry has witnessed significant developments over the last 12-18 months, shaping Adult and Pediatric Vaccines industry trends. Recent partnerships between pharmaceutical companies and research institutions have accelerated the development of innovative vaccine candidates. Notable mergers and acquisitions have also taken place, expanding the portfolio of major players in the market. Furthermore, several product and technology launches have improved vaccine efficacy and safety profiles.

Regulatory changes have also impacted the industry, with updated guidelines for vaccine approvals and increased funding for vaccine research. A shift in consumer trends towards preventive healthcare has driven demand for vaccines, while enterprises have invested heavily in vaccine development and distribution infrastructure. Additionally, funding rounds and expansions have enabled companies to scale up their vaccine production capabilities, ensuring a steady supply of vaccines to meet growing demand.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Adult and Pediatric Vaccines market. The market attractiveness of this sector is high, driven by increasing demand for preventive care and a growing awareness of vaccine-preventable diseases. The competitive intensity is moderate, with several key players dominating the market. The long-term Adult and Pediatric Vaccines market outlook is promising, with ongoing innovation in vaccine development and distribution. However, the demand-supply balance poses a challenge, with fluctuations in supply chain and manufacturing capabilities. Key risk factors include regulatory changes, vaccine hesitancy, and innovation landscape disruptions.

11 items

1. Executive Summary

2. Adult and Pediatric Vaccines Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Adult and Pediatric Vaccines Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Adult and Pediatric Vaccines Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Medical Care Centers

6.1.3. Others

6.2. Global Adult and Pediatric Vaccines Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Adult Vaccines

6.2.2. Pediatric Vaccines

6.3. Global Adult and Pediatric Vaccines Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Adult and Pediatric Vaccines Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Adult and Pediatric Vaccines Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Adult and Pediatric Vaccines Market Competition by Key Manufacturers

8.1. Global Adult and Pediatric Vaccines Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Adult and Pediatric Vaccines: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. GlaxoSmithKline

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Sanofi

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Merck

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Novartis

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Pfizer

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. AstraZeneca

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Johnson & Johnson

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Takeda Pharmaceutical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Bavarian Nordic

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. LG Life Sciences

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Sinovac Biotech

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Adult and Pediatric Vaccines Market

Figure 4: Global Adult and Pediatric Vaccines Market: Drivers

Figure 5: Global Adult and Pediatric Vaccines Market: Challenges

Figure 6: Global Adult and Pediatric Vaccines Market: Trends

Figure 7: Global Adult and Pediatric Vaccines Market: Opportunity

Figure 8: Global Adult and Pediatric Vaccines Market: Restraint

Figure 9: Global Adult and Pediatric Vaccines Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Adult and Pediatric Vaccines Market Value (USD Million) By Region

Figure 15: Global Adult and Pediatric Vaccines Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Adult and Pediatric Vaccines Market Value (USD Million) By Region

Figure 23: Global Adult and Pediatric Vaccines Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Adult and Pediatric Vaccines Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Adult and Pediatric Vaccines Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Adult and Pediatric Vaccines Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Adult and Pediatric Vaccines Market Value (USD Million) By Region

Table 10: Global Adult and Pediatric Vaccines Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Adult and Pediatric Vaccines Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Adult and Pediatric Vaccines Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Adult and Pediatric Vaccines Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: GlaxoSmithKline Basic Information And Sales Area

Table 31: GlaxoSmithKline. Products Portfolio

Table 32: Sanofi Basic Information And Sales Area

Table 33: Sanofi. Products Portfolio

Table 34: Merck Basic Information And Sales Area

Table 35: Merck. Products Portfolio

Table 36: Novartis Basic Information And Sales Area

Table 37: Novartis. Products Portfolio

Table 38: Pfizer Basic Information And Sales Area

Table 39: Pfizer. Products Portfolio

Table 40: AstraZeneca Basic Information And Sales Area

Table 41: AstraZeneca. Products Portfolio

Table 42: Johnson & Johnson Basic Information And Sales Area

Table 43: Johnson & Johnson. Products Portfolio

Table 44: Takeda Pharmaceutical Basic Information And Sales Area

Table 45: Takeda Pharmaceutical. Products Portfolio

Table 46: Bavarian Nordic Basic Information And Sales Area

Table 47: Bavarian Nordic. Products Portfolio

Table 48: LG Life Sciences Basic Information And Sales Area

Table 49: LG Life Sciences. Products Portfolio

Table 50: Sinovac Biotech Basic Information And Sales Area

Table 51: Sinovac Biotech. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Adult and Pediatric Vaccines Market Value (USD Million) By Region

Table 57: Global Adult and Pediatric Vaccines Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Adult and Pediatric Vaccines Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.50 billion
Revenue forecast in 2033	13.96 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GlaxoSmithKline; Sanofi; Merck; Novartis; Pfizer; AstraZeneca; Johnson & Johnson; Takeda Pharmaceutical; Bavarian Nordic; LG Life Sciences; Sinovac Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options